GREM1, FRZB and DKK1 mRNA levels correlate with osteoarthritis and are regulated by osteoarthritis-associated factors by Jeroen CH Leijten et al.
Leijten et al. Arthritis Research & Therapy 2013, 15:R126
http://arthritis-research.com/content/15/5/R126RESEARCH ARTICLE Open AccessGREM1, FRZB and DKK1 mRNA levels correlate
with osteoarthritis and are regulated by
osteoarthritis-associated factors
Jeroen CH Leijten1, Steffan D Bos2, Ellie BM Landman1, Nicole Georgi1, Holger Jahr3, Ingrid Meulenbelt2,
Janine N Post1, Clemens A van Blitterswijk4 and Marcel Karperien1*Abstract
Introduction: Osteoarthritis is, at least in a subset of patients, associated with hypertrophic differentiation of articular
chondrocytes. Recently, we identified the bone morphogenetic protein (BMP) and wingless-type MMTV integration site
(WNT) signaling antagonists Gremlin 1 (GREM1), frizzled-related protein (FRZB) and dickkopf 1 homolog (Xenopus laevis)
(DKK1) as articular cartilage’s natural brakes of hypertrophic differentiation. In this study, we investigated whether factors
implicated in osteoarthritis or regulation of chondrocyte hypertrophy influence GREM1, FRZB and DKK1 expression levels.
Methods: GREM1, FRZB and DKK1 mRNA levels were studied in articular cartilage from healthy preadolescents and
healthy adults as well as in preserved and degrading osteoarthritic cartilage from the same osteoarthritic joint by
quantitative PCR. Subsequently, we exposed human articular chondrocytes to WNT, BMP, IL-1β, Indian hedgehog,
parathyroid hormone-related peptide, mechanical loading, different medium tonicities or distinct oxygen levels and
investigated GREM1, FRZB and DKK1 expression levels using a time-course analysis.
Results: GREM1, FRZB and DKK1 mRNA expression were strongly decreased in osteoarthritis. Moreover, this
downregulation is stronger in degrading cartilage compared with macroscopically preserved cartilage from the same
osteoarthritic joint. WNT, BMP, IL-1β signaling and mechanical loading regulated GREM1, FRZB and DKK1 mRNA levels.
Indian hedgehog, parathyroid hormone-related peptide and tonicity influenced the mRNA levels of at least one
antagonist, while oxygen levels did not demonstrate any statistically significant effect. Interestingly, BMP and WNT
signaling upregulated the expression of each other’s antagonists.
Conclusions: Together, the current study demonstrates an inverse correlation between osteoarthritis and GREM1, FRZB
and DKK1 gene expression in cartilage and provides insight into the underlying transcriptional regulation. Furthermore,
we show that BMP and WNT signaling are linked in a negative feedback loop, which might prove essential in articular
cartilage homeostasis by balancing BMP and WNT activity.Introduction
A growing body of evidence suggests that hypertrophic
differentiation of articular chondrocytes underlies the
pathogenesis of osteoarthritis, at least in a subset of
patients [1]. However, healthy articular cartilage is
largely resistant to hypertrophic differentiation. In
recent years many factors that are able to influence, or
correlate with, the development of osteoarthritis have* Correspondence: H.B.J.Karperien@utwente.nl
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reproduction in any medium, provided the orbeen revealed. These include, but are not limited to,
bone morphogenetic proteins (BMPs) [2,3], canonical
wingless-type MMTV integration site family members
(WNTs) [4,5], Hedgehog [6], interleukins [7,8], para-
thyroid hormone-related peptide (PTHrP) [9] and the
transcription factors HIF2A [10] and RunX2 [11]. Of
these factors, BMPs [12], WNT [13], Indian hedgehog
(IHH) [14], HIF2A [15] and RunX2 [16] have also been
identified as prohypertrophic factors.
Regardless of the instigating factor, hypertrophic dif-
ferentiation of chondrocytes induces a catabolic shift.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lation, such as repetitive impulse loading [18], can also
induce a catabolic shift. Additionally, tonicity might play a
role in osteoarthritis, because it is significantly lower in
osteoarthritic joints and is able to drive the expression of
anabolic cartilage genes [19].
Healthy articular cartilage has an intrinsic mechan-
ism that protects it from undergoing hypertrophic dif-
ferentiation and subsequent catabolism [20]. Evidence
suggests that articular cartilage is able to inhibit hyper-
trophic differentiation. For example, articular cartilage
secretes soluble factors that inhibit hypertrophic differenti-
ation of growth plate cartilage and chondrogenically differ-
entiating mesenchymal stromal cells (MSCs) [21,22]. We
recently identified the BMP and WNT antagonists Gremlin
1 (GREM1), frizzled-related protein (FRZB) and dickkopf 1
homolog (Xenopus laevis) (DKK1) as prime candidates
for these articular cartilage secreted factors that inhibit
chondrocyte hypertrophy [23]. Moreover, we have demon-
strated that a SNP mutation in the GREM1 gene associates
with hip osteoarthritis [23].
Based on these observations, we hypothesized that the
expression of GREM1, FRZB and DKK1 is inversely corre-
lated with osteoarthritis and their expression is influenced
by established regulators of chondrocyte hypertrophy. In
this study we have addressed this hypothesis by analyzing
mRNA expression of GREM1, FRZB and DKK1 in human
cartilage biopsies and in primary human chondrocytes
stimulated with factors that are able to influence, or
correlate with, the development of osteoarthritis.
Methods
Patient material
The use of human material was approved by the medical
ethical committee of the Leiden University Medical Center.
Written informed consent was received from or on behalf of
all patients, including next-of-kin for child patients. Healthy
preadolescent articular cartilage was obtained from four
patients between 9 and 14 years old that underwent ampu-
tation surgery with cartilage-unrelated etiologies. Healthy
adult articular was obtained from three post-mortem donors
(70.3 ± 11.2 years). Through the ongoing RAAK study [24]
we sampled 23 donor joints (66.9 ± 9.9 years) with primary
osteoarthritis during joint replacement surgery; cartilage
specimens from areas visibly affected by the osteoarthritis
process (osteoarthritis cartilage) and areas that appeared
macroscopically intact (preserved cartilage) were taken
for mRNA isolation and were analyzed pairwise.
Cell isolation and cultivation
Macroscopically intact articular cartilage from osteoarthritic
femoral condyles was obtained from patients undergoing
total knee replacement to establish primary chondrocyte
cultures. Bovine cartilage of the femoral condyle wasobtained from a local abattoir. Chondrocytes were isolated
by collagenase treatment and cultured as previously
described [25]. Chondrocytes were used in passage 2
unless otherwise stated. One should note that expression
of GREM1, FRZB and DKK1 is not significantly altered
between passage 0 and passage 2 chondrocytes (data not
shown). Bone marrow-derived MSCs were isolated and
cultured as described previously [26]. MG63 and Saos-2
were cultured in Dulbecco’s modified Eagle’s medium
(Gibco, Grand Island, NY, USA) containing 10%
heat-inactivated fetal bovine serum (Biowhittaker,
Walkersville, MD, USA), 100 U/ml penicillin (Gibco)
with 100 mg/ml streptomycin (Gibco).
Oxygen levels
Freshly isolated human chondrocytes were seeded at
2,500 cells/cm2 and cultured under conventional normoxic
culture conditions (21% oxygen) or under hypoxic cul-
ture conditions (2.5% oxygen) using a hypoxia incubator
(proox model C21; Biospherix, Redfield, NY, USA). Cells
were cultured until 95% confluency was reached.
Tonicity
Chondrocytes were seeded at 7,500 cells/cm2, expanded
in culture medium that was adjusted to either 280 or
380 mOsm, which approximates the osmolarity found
in the synovial fluid of an osteoarthritic and healthy
joint respectively [27]. We therefore refer to 280 mOsm
as being hypotonic. The osmolarity of the culture medium
was adjusted with sodium chloride and reseeded at 20,000
cells/cm2 as previously described [19]. After 24 hours, 0 or
500 ng/ml calcineurin inhibitor FK506 was supplemented
to the culture medium. FK506 inhibits calcineurin-
dependent NFAT signaling, which has been described to
mediate tonicity-induced cell signaling in chondrocytes
[19]. After an additional 6 days the chondrocytes were
lysed for gene expression analysis.
Mechanical stimulation
A medium suspension of passage 2 human chondrocytes
was mixed in a 1:1 ratio with liquefied ultrapure agarose
(Invitrogen, Carlsbad, CA, USA) and loaded into a
stainless steel bioreactor to create four 70 μl constructs
of two percent agarose containing 10×106 cells/ml. The
insert, loaded with four constructs, was installed in a
custom-build bioreactor [28]. Using a custom-designed
compression plate, two out of four constructs were mechan-
ically loaded with 0.5 MPa, while the other two constructs
remained unloaded. Compression was applied in a cyclical
fashion with a frequency of 0.33 Hz with a loading phase of
50%. During 48 hours, the loaded samples were either cyc-
lically compressed without interruption (constant loading)
or were unloaded for 1 hour after being cyclically com-
pressed for 1 hour (intermittent loading).
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All cell types were seeded at 5,000 cells/cm2, grown to 95%
confluency and subsequently exposed to a single dose of re-
combinant proteins. In all stimulation experiments, primary
human chondrocytes of intact osteoarthritic cartilage,
bovine chondrocytes of healthy articular cartilage, human
bone marrow-derived MSCs or the cell lines MG63 and
Saos-2 were used at passage 2. Cells received no medium
refreshment after stimulation had occurred and were
cultured up to 96 hours unless otherwise stated.
Human chondrocytes were exposed to 4, 20, 100 or
200 ng/ml recombinant human BMP2 (catalogue number
355-BM-010; R&D Systems, Minneapolis, MN, USA),
100 ng/ml recombinant human WNT3A (catalogue
number 5036-WN-010; R&D Systems), 100 ng/ml re-
combinant human DKK1 (catalogue number 5439-DK
-010; R&D Systems), 3, 10 or 30 nM GSK3β inhibitor GIN
[29], 0.3, 1 or 3 μM canonical WNT inhibitor PKF115-584
[30], 10 or 100 ng/ml recombinant human (catalogue num-
ber IL1B 201-LB-005; R&D Systems), 10 μM hedgehog sig-
naling blocker cyclopamine (catalogue number BML-
GR334-0001; Enzo Life Sciences, Farmingdale, NY, USA),
2.5 μg/ml recombinant IHH (catalogue number 1705-HH-
025; R&D Systems) or 5×10–7 M recombinant human
PTHrP (catalogue number SRP4651-50; Sigma Aldrich, St
Louis, MO, USA). Second-passage human and bovine
chondrocytes, second-passage human MSCs, MG63 and
Saos-2 were stimulated with 10 nM GIN and 100 ng/ml
recombinant human WNT3A.
Quantitative real-time RT-PCR
At designated time points, cells were washed with PBS
and lysed using trizol reagent (Invitrogen). Total RNA iso-
lation, cDNA synthesis and gene expression analysis were
performed as described previously [26]. Gene expression
is reported as the relative fold-change between treated
samples and untreated controls and is normalized to 0
hours post treatment unless stated otherwise. Primer
sequences are available on our website [31].
Viability
Passage 2 human chondrocytes were seeded at 3,000
cells/cm2. Upon reaching 95% confluency the chondrocytes
were treated with 3, 10, 30 nM GIN, 0.3, 1, 3 μM PKF115-
584, 100 ng/ml DKK1 or 100 ng/ml WNT3A. After 48
hours the total metabolic activity of the cells was mea-
sured using Alamar blue (Invitrogen) according to the
manufacturer’s protocol.
Statistical analysis
Statistical differences between experimental treatments
were analyzed using Student’s t test or one-way analysis
of variance. Each group consisted of three different do-
nors, each measured at least in triplicate. Correlationbetween the expression of different genes was calculated
using Pearson correlation. Statistical significance was
set to P <0.05.
Results
GREM1, FRZB and DKK1 mRNA levels are decreased in
osteoarthritic cartilage
Osteoarthritic cartilage is characterized by evidence of
increased hypertrophic differentiation in at least a subset
of patients [32]. Recently we reported that FRZB, GREM1
and DKK1 function as natural brakes of the hypertrophic
differentiation of articular cartilage [23]. Based on their pro-
posed role, we hypothesized that the expression of these
genes was decreased in osteoarthritic cartilage. GREM1,
FRZB and DKK1 mRNA expression levels were therefore
determined in paired specimens of macroscopically rela-
tively preserved and degenerating osteoarthritic cartilage
collected from a single osteoarthritic joint for 23 patients,
healthy preadolescent cartilage and healthy adult articular
cartilage. Healthy preadolescent and healthy adult ar-
ticular cartilage both express these three genes at sig-
nificantly higher levels than preserved and degrading
osteoarthritic cartilage. Moreover, GREM1, FRZB and
DKK1 mRNA is significantly lower in degrading cartil-
age compared with macroscopically preserved cartilage
(Figure 1) by 5.86-fold, 4.34-fold and 2.83 fold respectively
(in Additional file 1: Figure S1A). In addition, we demon-
strated that this decrease is reproducible in almost all tested
patients, with the exception of the patients with the lowest
GREM1, FRZB and DKK1 mRNA expression levels. Finally,
we demonstrated that the expression of all three genes was
positively correlated with each other (in Additional file 1:
Figure S1B).
BMP2 enhances transcription of WNT antagonist FRZB
and DKK1
Human chondrocytes were stimulated with a single pulse of
BMP2 for up to 48 hours to investigate its effect on GREM1,
FRZB and DKK1 mRNA levels. Functionality of the recom-
binant protein was demonstrated by a dose-dependent in-
duction of the BMP target gene ID1. GREM1 mRNA levels
remained unaltered compared with untreated chondrocytes
after 48 hours. However, the expression of the WNT antag-
onists FRZB and DKK1 were significantly upregulated in a
dose-dependent manner (Figure 2). This suggests that BMPs
were able to induce inhibition of canonical WNT signaling
in a dose-dependent manner. Indeed, the WNT target gene
AXIN2 was downregulated in a dose-dependent manner
after BMP2 treatment.
Canonical WNT signaling downregulates GREM1, FRZB
and DKK1 expression
Chondrocytes were cultured in the presence or ab-
sence of either 100 ng/ml recombinant WNT3A, or a
Figure 1 GREM1, FRZB and DKK1 expression in healthy cartilage and osteoarthritic cartilage. Relative GREM1, FRZB and DKK1 mRNA
expression levels of paired specimens of macroscopically preserved and degenerating osteoarthritic cartilage from a single osteoarthritic joint
(n = 23) were assessed by quantitative PCR and were compared with healthy preadolescent (n = 4) and healthy adult (n = 3) articular cartilage
specimen. Data expressed as fold-change relative to the specimen with the mRNA expression level on a log scale. *P <0.05. DKK1, dickkopf 1
homolog (Xenopus laevis); FRZB, frizzled-related protein; GADPH, glyceraldehyde 3-phosphate dehydrogenase; GREM1, Gremlin 1; OA, osteoarthritis.
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canonical WNT signaling. Both WNT3A and GIN dose-
dependently upregulated AXIN2 mRNA expression 48
hours after stimulation (Figure 3A). None of the condi-
tions showed any signs of cytotoxicity as determined
by phenotypical appearance and metabolic activity of
the cells (Additional file 2).
Chondrocytes were then cultured in the presence or
absence of 100 ng/ml WNT3A or 10 nM GIN up to 96
hours. Both GIN and WNT3A induced canonical WNT
signaling evidenced by an increase in AXIN2 mRNA
expression. The effect was first detected after 6 hours
and peaked between 24 and 48 hours post stimulationFigure 2 Effects of bone morphogenetic protein signaling on
the mRNA expression of GREM1, FRZB and DKK1. Chondrocytes
were stimulated for 48 hours with different concentrations of BMP2
ranging from 0 to 200 ng/μl. Effects on gene expression of GREM1,
FRZB, DKK1, AXIN2 and DKK1 were analyzed using quantitative PCR.
Data expressed as fold-change relative to control and represents the
mean of three donors ± standard deviation. *P <0.05 compared with
0 ng/ml BMP2. BMP2, bone morphogenetic protein 2; DKK1,
dickkopf 1 homolog (Xenopus laevis); FRZB, frizzled-related protein;
GADPH, glyceraldehyde 3-phosphate dehydrogenase; GREM1,
Gremlin 1.(Figure 3B). FRZB and DKK1 mRNA levels started to
decrease 48 hours after stimulation and were significantly
lower after 72 and 96 hours compared with untreated
samples. This suggested that activation of WNT signaling
resulted in the downregulation of WNT antagonists
(Figure 3C, D). Activation of canonical WNT signaling
transiently decreased GREM1 mRNA expression with
lowest levels of mRNA expression 24 hours after treatment,
after which the expression levels gradually returned to
control levels (Figure 3E).
Additionally, we investigated the effects of enhanced
WNT signaling on the mRNA levels of CHRD and
CHRDL2, two BMP antagonists that have been suggested
to play an inhibitory role in hypertrophic differentiation
of chondrocytes [33,34]. Activation of canonical WNT
signaling reduced CHRD and CHRDL2 mRNA levels
with a maximal effect after 72 hours (in Additional file 3:
Figure S3A, B). This suggested that activation of canonical
WNT signaling might be able to influence BMP signaling
by decreasing the expression of BMP antagonists. Indeed,
mRNA levels of the established BMP target gene ID1 in-
creased upon stimulation of canonical WNT signaling. This
increase was preceded by a decrease in BMP antagonists’
gene transcription (Figure 3F).
Canonical WNT signaling regulates GREM1, FRZB and
DKK1 mRNA levels in bovine chondrocytes, MG63, SAOS2,
and human mesenchymal stromal cells
As activation of canonical WNT signaling is correlated
with a catabolic response in cartilage, at least in animal
models, it is paramount for joint homeostasis that WNT
signaling is tightly controlled. Typically, activation of critical
pathways is accompanied by subsequent activation of nega-
tive feedback loops reducing pathway activity. Surprisingly,
activation of canonical WNT signaling in primary human
chondrocytes resulted in decreased FRZB and DKK1
Figure 3 Effect of canonical WNT signaling on the mRNA expression of GREM1, FRZB and DKK1. (A) Primary human chondrocytes were
exposed to 100 ng/ml WNT3A or three different concentrations of GIN. After 48 hours, AXIN2 mRNA expression was analyzed by quantitative PCR.
(B) to (F) Chondrocytes were exposed to a single dose of 10 nM GIN or 100 ng/ml WNT3A. At indicated time points, mRNA expression was
analyzed by quantitative PCR of AXIN2 (B), FRZB (C), DKK1 (D), GREM1 (E) and ID1 (F). Data expressed as fold-change relative to untreated
time-point-matched control and represents the mean of three donors ± standard deviation. *P <0.05 compared with unstimulated cells (A) or 0
hours of stimulation (B) to (F). DKK1, dickkopf 1 homolog (Xenopus laevis); FRZB, frizzled-related protein; GADPH, glyceraldehyde 3-phosphate
dehydrogenase; GREM1, Gremlin 1; WNT, wingless-type MMTV integration site.
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this downregulation was restricted to articular chondrocytes
or was a general response across different cell types. Bovine
chondrocytes, MG63s, SAOS-2 and MSCs were exposed
to 100 ng/ml WNT3A or 10 nM GIN for 48 hours. Com-
parable with human chondrocytes, bovine chondrocytes
downregulated FRZB and DKK1 mRNA levels after activa-
tion of canonical WNT signaling. In contrast, MG63 and
SAOS-2 did not respond to GIN with changes in expres-
sion of FRZB and GREM1, respectively (Additional file 4).
Like chondrocytes, human bone marrow-derived MSCs
demonstrated a decrease in FRZB and DKK1 mRNA levels
upon stimulation of canonical WNT signaling. In contrast
to human chondrocytes, GREM1 mRNA expression was
upregulated by activating WNT signaling. Together this
suggested that the response to canonical WNT signaling
stimulation with regards to the mRNA expression levels of
WNT and BMP antagonists is cell type dependent, but is
conserved between species in articular chondrocytes.
Inhibition of canonical WNT signaling induces mRNA
expression of GREM1, FRZB and DKK1
We next investigated the effect of inhibiting canonical
WNT signaling on the mRNA expression levels of GREM1,
FRZB and DKK1 using 100 ng/ml WNT antagonist DKK1
or 0.3, 1 or 3 μM canonical WNT inhibitor PKF115-584.
Treatment of human chondrocytes for 48 hours with either
WNT inhibitor significantly reduced AXIN2 mRNA levels,except for 0.3 μM PKF115-584 (in Additional file 5: Figure
S5A). Treatment with 1 or 3 μM PKF115-584 reduced the
chondrocyte’s metabolic activity and chondrocytes treated
with 3 μM PKF115-584 showed phenotypical signs of stress
(Additional file 2). A concentration of 1 μM PKF115-584
was therefore selected for further experimentation.
Treatment of chondrocytes up to 96 hours with a single
dose of 100 ng/ml DKK1 or 1 μM PKF115-584 resulted in
a progressive decrease in AXIN2 mRNA levels, which be-
came statistically significant between 72 and 96 hours post
treatment (in Additional file 5: Figure S5B). In contrast,
FRZB and DKK1mRNA levels steadily increased over time,
which became significant between 24 and 48 hours post
exposure (in Additional file 5: Figure S5C, D). Treatment
with DKK1 or PKF115-584 increased GREM1 mRNA levels
and this coincided with a subsequent decrease in ID1
mRNA levels (in Additional file 5: Figure S5E, F). Taken
together, these data suggested that in human chondrocytes
the GREM1, FRZB and DKK1 mRNA levels were inversely
related to the activity of canonical WNT signaling.
Effects of IL-1β stimulation on GREM1, FRZB and DKK1
mRNA expression
Local injection of IL-1β into mouse knee joints resulted
in the destabilization of joint homeostasis by inducing a
catabolic shift in the articular cartilage [35]. We therefore
investigated the effect of IL-1β on GREM1, FRZB and
DKK1 mRNA levels. Chondrocytes were stimulated with
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repeated dose of 10 ng/ml IL-1β. Upon exposure to a single
dose of IL-1β, GREM1 mRNA levels decreased at 6 hours
followed by a steady increase in mRNA expression, which
became significantly higher than untreated samples after
72 hours. Interestingly, repeated treatment with of IL-1β
decreased GREM1 mRNA expression after 6 hours, which
returned to baseline after 24 hours (Figure 4A). FRZB
mRNA levels were dose-dependently downregulated after
exposure to IL-1β. Daily treatment with 10 ng/ml was as
effective as a pulse treatment with 100 ng/ml. DKK1
mRNA levels decreased after stimulation with IL-1β.
This downregulation was transient with a single dose but
persistent with a daily dose of IL-1β (Figure 4B, C).Effects of physiological factors on GREM1, FRZB and DKK1
mRNA transcription
Many physiological factors influence the homeostasis
of articular cartilage. To determine whether such stimuli
have an effect on the mRNA expression levels of GREM1,
FRZB and DKK1, chondrocytes were exposed to, for
example, differing mechanical compression, oxygen tension
and tonicity.
Chondrocytes encapsulated in three-dimensional hydrogels
were cultured in the presence or absence of cyclic loading
of the construct with 0.5 MPa with a frequency of 0.33 Hz,
which was either continuously or intermittently applied
over a culture period of 48 hours. Both continuous and
intermittent loading significantly elevated GREM1 and
FRZBmRNA levels compared with unloaded chondrocytes.
DKK1 mRNA levels were only significantly increased
after intermittent loading of the construct (Figure 5A).
Interestingly, intermittent loading was more effective in
upregulating GREM1, FRZB and DKK1 mRNA expression
than continuous loading.
Articular cartilage predominantly persists in a continuous
state of hypoxia. Relief of this hypoxic stress is able toFigure 4 Effects of IL-1β-mediated signaling on mRNA expression of
or 100 ng/ml IL-1β, or a daily medium refreshment containing 10 ng/ml IL
expression was analyzed by quantitative PCR at the indicated time points f
relative to untreated time point-matched control and represent the mean
unstimulated cells. DKK1, dickkopf 1 homolog (Xenopus laevis); FRZB, frizzled
GREM1, Gremlin 1.stimulate hypertrophic differentiation of hyaline cartil-
age [36]. Chondrocytes were therefore cultured under
hypoxic (2.5%) or normoxic (21%) conditions. No de-
tectable changes in GREM1, FRZB and DKK1 mRNA
levels were observed between normoxic and hypoxic
culture conditions (Figure 5B).
Osteoarthritis is associated with a decrease in tonicity
of the synovial fluid and cartilage [27]. We therefore
investigated the effect of tonicity on the mRNA levels of
GREM1, FRZB and DKK1. Tonicity did not detectably
affect GREM1 mRNA levels (Figure 5C). In contrast,
tonicity tended to increase DKK1 mRNA levels and
significantly increased FRZB mRNA levels. This effect was
NFAT independent because FK506, which indirectly
inhibits NFAT nuclear translocation, had no significant
effect on GREM1, FRZB and DKK1 mRNA levels.
Effects of PTHrP, IHH and cyclopamine on GREM1, FRZB
and DKK1 mRNA expression
PTHrP and IHH expression in articular cartilage is corre-
lated with osteoarthritis [6,9]. In addition, PTHrP and IHH
critically regulate the pace of hypertrophic differentiation in
growth plate cartilage in a negative feedback loop. As
GREM1, FRZB and DKK1 were able to inhibit hypertrophic
differentiation in articular cartilage and mitigated longi-
tudinal bone growth in explanted mouse fetal long bones
[23], we investigated whether PTHrP and IHH were
able to influence their mRNA expression. Chondrocytes
were cultured up to 96 hours in the presence or absence
of PTHrP, IHH and the hedgehog signaling blocker
cyclopamine. GREM1 mRNA expression remained un-
changed when stimulated with PTHrP, tended to tran-
siently decrease after stimulation with IHH and was
significantly increased by cyclopamine after 72 and 96
hours (in Additional file 6: Figure S6A). PTHrP nor
IHH affected FRZB mRNA levels. Cyclopamine tended
to decrease FRZB mRNA expression but this did not
reach significance (in Additional file 6: Figure S6B). InGREM1, FRZB and DKK1. Chondrocytes received a single dose of 10
-1β. Chondrocytes were stimulated up to 96 hours and mRNA
or GREM1 (A), FRZB (B), and DKK1 (C). Data expressed as fold-change
of three donors ± standard deviation. *P <0.05 compared with
-related protein; GADPH, glyceraldehyde 3-phosphate dehydrogenase;
Figure 5 Effects of physiological factor-mediated signaling on mRNA expression of GREM1, FRZB and DKK1. Effects of mechanical
loading, oxygen level and medium tonicity mediated signaling on mRNA expression of GREM1, FRZB and DKK1. Chondrocytes encapsulated in a
hydrogel received no, intermittent or constant cyclical mechanical loading of 0.5 MPa with a frequency of 0.33 Hz and a loading phase of 50%
(A). Chondrocytes were exposed to normoxic or hypoxic culture conditions (B), or were cultured in media with different tonicity with or without
FK506 (C). All conditions were analyzed for the mRNA expression of GREM1, FRZB and DKK1 by quantitative PCR after 48 hours. Data expressed as
fold-change relative to control and represent the mean of three donors ± standard deviation. *P <0.05 compared with unloaded samples or
samples containing medium of 280 mOsm. DKK1, dickkopf 1 homolog (Xenopus laevis); FRZB, frizzled-related protein; GADPH, glyceraldehyde
3-phosphate dehydrogenase; GREM1, Gremlin 1.
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creased by cyclopamine and PTHrP treatment from 24 and
72 hours, respectively, but not by IHH (in Additional file 6:
Figure S6C). The expression of established hedgehog and
PTHrP target genes was used to verify the biological activity
of each stimulus. GLI1 mRNA levels increased in the
presence of IHH (in Additional file 6: Figure S6D) and
decreased in the presence of cyclopamine (in Additional
file 6: Figure S6E). CCND1 mRNA levels increased in the
presence of PTHrP (in Additional file 6: Figure S6F). Taken
together, this suggested that inhibition, but not activation,
of IHH upregulated GREM1 and DKK1 mRNA levels.
Discussion
Recently we have reported that GREM1, FRZB and DKK1
are enriched in articular cartilage compared with other hya-
line cartilage types and act as potent inhibitors of hyper-
trophic differentiation [23]. Moreover, we demonstrated an
association between a genetic variation (SNP rs12593365)
in a genomic control region of GREM1 and radiographic
osteoarthritis of the hip. Based on these and other data we
provided evidence that these BMP and WNT antagonists
are important regulators of articular cartilage homeostasis
by preventing hypertrophic differentiation of chondrocytes
[23]. Since osteoarthritis is associated with deregulated
hypertrophic differentiation in at least a subset of patients,
we hypothesized that GREM1, FRZB and DKK1 mRNA
expression levels are downregulated in osteoarthritis. In
this study we report that the expression of GREM1, FRZB
and DKK1 mRNA was strongly decreased in osteoarthritic
cartilage compared with healthy cartilage and was also
decreased in degrading osteoarthritic cartilage compared
with macroscopically preserved cartilage from the same
osteoarthritic joint. In addition, we report on the effects
of biochemical and biophysical stimuli associated with
chondrocyte hypertrophy on GREM1, FRZB and DKK1mRNA expression. Although the enzymatic isolation of
the chondrocytes may have affected their gene expression
levels, they were directly in line with our hypothesis. Fur-
thermore, our claims are furthermore supported by recent
observations demonstrating that osteophytic cartilage,
which is prone to undergo endochondral ossification, has
significantly less expression of GREM1 and FRZB compared
with permanent articular cartilage [37].
GREM1, FRZB and DKK1 are secreted soluble antago-
nists. FRZB and DKK1 are WNT antagonists and GREM1
is a BMP antagonist. GREM1 is also able to inhibit WNT
signaling via unknown indirect mechanisms [38] and BMP
signaling is able to repress WNT signaling [39]. Conversely,
WNT signaling is also able to repress BMP signaling
[40]. Activation of WNT signaling is well known to inhibit
fibroblastic growth factor-dependent BMP repression [41].
Indeed, increased canonical WNT signaling resulted in
increased BMP/SMAD signaling [42]. Although the cross-
talk between BMP and WNT signaling is suggested to in-
volve SMAD4 and MAPK p38, the exact mechanism has
remained largely unknown [43].
Understanding the crosstalk between transforming growth
factor beta/BMP and WNT signaling is desired because it
plays important roles in the formation of several tissues,
including bone, cartilage and intestinal epithelium [42,43].
While in previous studies the interplay is mainly character-
ized by activation of each other’s ligands, in our study we
provide evidence that antagonists may also play a central
role in the crosstalk. We demonstrated in chondrocytes
that this crosstalk is mediated, at least partially, via recipro-
cal transcriptional control of each other’s antagonists. Con-
sequently, our data suggest that the crosstalk between
transforming growth factor beta/BMP and WNT signaling
might act as a feedback loop that balances the activity of
both pathways (Figure 6A). Specifically, activation of WNT
signaling downregulates the expression of genes encoding
Figure 6 Preliminary working model of WNT and BMP signaling feedback loop and perturbation by osteoarthritis factors. (A) WNT and
BMP signaling reciprocally regulates the transcription of other antagonists. Exposure of WNT agonists leads to activation of WNT signaling [1]. This
activation results in the downregulation of WNT antagonists (for example, FRZB and DKK1), leading to less inhibition of WNT signaling [2].
Additionally, BMP antagonists (for example, GREM1) are downregulated, leading to less inhibition of BMP signaling [3]. Stronger BMP signaling
results in the upregulation of WNT antagonists [4], establishing a negative feedback mitigating WNT signaling [5]. This feedback loop allows for
tight control of both BMP and WNT signaling in articular cartilage contributing to homeostasis. (B) Established factors that influence cartilage
homeostasis also perturb this feedback loop. IL-1β, lack of mechanical stimulation and tonicity all decrease the mRNA levels of WNT and BMP
antagonists, possibly resulting in a reset of the feedback loop, and contributing to the loss of cartilage homeostasis. BMP, bone morphogenetic
protein; DKK1, dickkopf 1 homolog (Xenopus laevis); FRZB, frizzled-related protein; GADPH, glyceraldehyde 3-phosphate dehydrogenase; GREM1,
Gremlin 1; WNT, wingless-type MMTV integration site.
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BMP signaling. In turn, activation of BMP signaling results
in increased expression of genes encoding WNT antago-
nists, which is associated with decreased WNT signaling.
Stringent control over the WNT pathway’s activity is
paramount for articular cartilage homeostasis because
both exacerbated and repressed signaling results in an
osteoarthritis-like phenotype, at least in animal models
[44,45]. Perturbation of feedback loops that control the
activity of WNT signaling would therefore allow for the
disturbance of the natural homeostasis. Factors associated
with disturbed joint homeostasis include, amongst others,
IL-1β, abnormal mechanical loading and hypotonicity. Al-
though evidence suggests that short exposure to IL-1β re-
sults in minor joint inflammation without permanent joint
destruction, continuous exposure to IL-1β results in joint
degradation that bears striking resemblance with osteoarth-
ritis [7,34]. Interestingly, IL-1β activates WNT signaling via
a currently unknown mechanism [46]. Excessive mechan-
ical loading of the joint induces the expression of IL-1β and
catabolic proteins [47]. Interestingly, reduced joint loading
by, for example, immobilization also results in increased
catabolism via the upregulation of matrix metalloproteinases
and aggrecanases [48]. In contrast, loading within the
physiological range inhibits the expression of catabolic genes
and shows a chondroprotective effect in the presence of IL-
1β [49]. Additionally, mechanical loading is able to regulate
the activity of WNT signaling via a currently unknown
mechanism [50]. Tonicity is able to regulate the expression
of interleukins including IL-1β [51]. However, its effect on
WNT signaling has remained largely uninvestigated. In this
study, we present data implying that IL-1β, lack of mechan-
ical loading and hypotonicity downregulate the expression
of the genes encoding hypertrophic differentiation inhibiting
proteins including GREM1, FRZB and DKK1 (Figure 6B).Our data suggest that these factors might be able to
perturb the balance between BMP and WNT signaling
by influencing the expression of both WNT and BMP
antagonists in a manner that cannot be sequestered via
their regular feedback loops. Consequently, it is tempting
to speculate that these factors may contribute to an
osteoarthritic-like phenotype, at least partially, via their abil-
ity to disturb the balance between WNT and BMP signal-
ing. Although additional research is needed to sustain such
a claim, recent evidence demonstrated that the addition of
WNT and BMP antagonist sclerostin was able to prevent
an IL-1β-induced osteoarthritis-like phenotype [52].
Stimulation with BMPs, WNTs, IL-1, IHH, PTHrP,
oxygen concentrations, change in tonicity and mechanical
loading may also influence the expression of WNT and
BMP antagonists other than GREM1, FRZB and DKK1.
Furthermore, such stimulation might also influence the ex-
pression of WNT and BMP agonists, at least at the mRNA
level. Moreover, it remains to be noted that the current
study is indeed limited to mRNA expression and not pro-
tein abundance. Nonetheless, clinical studies have shown
that DKK1 and FRZB protein expression in serum and/or
synovial fluid are expressed at significantly different levels
in patients with osteoarthritis or rheumatoid arthritis com-
pared with control [53,54]. Similarly decreased DKK1 levels
are found in synovial fluid of animal models of osteoarth-
ritis. Interestingly, DKK1 supplementation has recently
been shown to protect from experimental osteoarthritis
[55]. Lastly, several other BMP and WNT related proteins
have been indicated as being either protective or destructive
for articular cartilage [56,57]. These observations are in line
with our hypothesis and emphasize that stringent control
over DKK1, FRZB and GREM1 expression is required to
maintain cartilage homeostasis by preventing hypertrophic
chondrocyte differentiation and subsequent catabolism.
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The current study demonstrates that the mRNA expression
of GREM1, FRZB and DKK1 is inversely correlated
with the level of cartilage degeneration in osteoarth-
ritis. Moreover, the expression of these regulators of
chondrocyte hypertrophy can be influenced by regulators
of chondrocyte hypertrophy. Together, this provides a
deeper understanding of chondrocyte behavior, cartilage
homeostasis and osteoarthritis.Additional files
Additional file 1: Figure S1. Showing correlation of GREM1, FRZB and
DKK1 mRNA expression in preserved and degrading cartilage from the
same osteoarthritic joint (OA). (A) GREM1, FRZB and DKK1 mRNA levels
were determined in preserved and degenerated cartilage from the same
joint. All three antagonists are significantly less expressed in degenerated
cartilage compared with preserved cartilage of the same joint (n = 23).
Broken line indicates the cartilage specimen that belongs to the same
donor. (B) GREM1, FRZB and DKK1 were investigated on correlation of
mRNA expression. Correlation was determined using Pearson correlation.
GADPH, glyceraldehyde 3-phosphate dehydrogenase.
Additional file 2: Figure S2. Showing that cytotoxicity was
phenotypically investigated by assessing chondrocyte morphology. Cells
were exposed to DMSO, 100 ng/nl WNT3A, and 100 ng/ml DKK1 (A), a
concentration range of GIN (B) and a concentration range of PKF115-584
(C). A representative picture of each condition over time is shown. To
further investigate cytotoxicity, the metabolic activity of chondrocytes
exposed to the different conditions was determined using Alamar Blue
quantification (D). Data represent the mean of three donors ± standard
deviation. DMSO, dimethylsulfoxide.
Additional file 3: Figure S3. Showing that WNT signaling decreases
chordin and chordin-like 2 mRNA expression in primary human
chondrocytes. Gene expression was measured by quantitative PCR.
Chondrocytes were exposed to a single dose of 10 nM GIN, 100 ng/ml
WNT3A (A), (B), 1 μM PKF115-584 or 100 ng/ml DKK1 (C), (D) for up to 72
hours and analyzed for the gene transcription of CHRD (A, C) and CHRDL2
(B, D). Data represent the mean of three donors ± standard deviation. *P
<0.05 compared with untreated time point-matched controls. GADPH,
glyceraldehyde 3-phosphate dehydrogenase.
Additional file 4: Figure S4. Showing effects of activation of canonical
WNT signaling on the mRNA expression of GREM1, FRZB and DKK1 in cells
other than human chondrocytes. A single dose of 100 ng/ml WNT3A or
10 nM GIN was added to the culture media of bovine chondrocytes, the
MG63 cell line, the SAOS-2 cell line and human bone marrow-derived
MSCs. After 48 hours the gene transcription levels of GREM1 (A), FRZB (B)
and DKK1 (C) were analyzed. Data represent the mean of three
independent experiments (bovine chondrocytes, MG63 and SAOS-2) or
two donors (MSCs) ± standard deviation. *P <0.05 compared with
untreated time point-matched controls. GADPH, glyceraldehyde
3-phosphate dehydrogenase.
Additional file 5: Figure S5. Showing effect of canonical WNT
signaling on the mRNA expression of GREM1, FRZB and DKK1. Primary
human chondrocytes were exposed to 100 ng/ml WNT3A or three
different concentrations of PKF115-584 (115). After 48 hours AXIN2 mRNA
expression was analyzed by quantitative PCR. (A) Primary human
chondrocytes were then exposed to 1 μM PKF115-584 or 100 ng/ml
DKK1 for up to 96 hours. At indicated time points, gene expression was
analyzed by quantitative PCR of AXIN2 (B), FRZB (C), DKK1 (D), GREM1, (E)
and ID1 (F). Data expressed as fold-change relative to control and
represents the mean of three donors ± standard deviation. *P <0.05
compared with untreated time point-matched controls (G) or 0 hours of
stimulation (A to F). GADPH, glyceraldehyde 3-phosphate dehydrogenase.
Additional file 6: Figure S6. Showing effects of IHH-mediated or
PTHrP-mediated signaling on the mRNA expression of GREM1, FRZB andDKK1. Chondrocytes were exposed to 2.5 μg/ml IHH, 10 μM cyclopamine,
or 5×10–7 M PTHrP for up to 96 hours. At the indicated time points,
mRNA expression was analyzed by quantitative PCR of GREM1 (A), FRZB
(B), DKK1 (C), GLI1 (D-E) and CCND1 (F). Data expressed as fold-change
relative to control and represent the mean of three donors ± standard
deviation. *P <0.05 compared with untreated time point-matched
controls. GADPH, glyceraldehyde 3-phosphate dehydrogenase.
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